Musco Mxt

Aralia Quinquefolia, Epiphegus Virginiana, Jacaranda Caroba, Lacticum Acidum, Hydrocotyle Asiatica, Hydrocyanicum Acidum,


Sandco International, Inc
Human Otc Drug
NDC 49892-0002
Musco Mxt also known as Aralia Quinquefolia, Epiphegus Virginiana, Jacaranda Caroba, Lacticum Acidum, Hydrocotyle Asiatica, Hydrocyanicum Acidum, is a human otc drug labeled by 'Sandco International, Inc'. National Drug Code (NDC) number for Musco Mxt is 49892-0002. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Musco Mxt drug includes Centella Asiatica - 100 [hp_C]/mL Epifagus Virginiana - 15 [hp_C]/mL Hydrogen Cyanide - 100 [hp_C]/mL Jacaranda Caroba Flower - 15 [hp_C]/mL Lactic Acid, Dl- - 15 [hp_C]/mL Panax Quinquefolius Whole - 15 [hp_C]/mL . The currest status of Musco Mxt drug is Active.

Drug Information:

Drug NDC: 49892-0002
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Musco Mxt
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Aralia Quinquefolia, Epiphegus Virginiana, Jacaranda Caroba, Lacticum Acidum, Hydrocotyle Asiatica, Hydrocyanicum Acidum,
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Sandco International, Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CENTELLA ASIATICA - 100 [hp_C]/mL
EPIFAGUS VIRGINIANA - 15 [hp_C]/mL
HYDROGEN CYANIDE - 100 [hp_C]/mL
JACARANDA CAROBA FLOWER - 15 [hp_C]/mL
LACTIC ACID, DL- - 15 [hp_C]/mL
PANAX QUINQUEFOLIUS WHOLE - 15 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 27 Jun, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Sandco International, Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0367803006609
UPC stands for Universal Product Code.
UNII:7M867G6T1U
69J42KMV8D
2WTB3V159F
0JTX26L7CL
3B8D35Y7S4
0P067WOA1X
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
49892-0002-130 mL in 1 BOTTLE, DROPPER (49892-0002-1)27 Jun, 2013N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications improves hypertrophy, muscular weakness, stiffness in joints and lactic acid buildup due to prolonged physical effort.

Product Elements:

Musco mxt aralia quinquefolia, epiphegus virginiana, jacaranda caroba, lacticum acidum, hydrocotyle asiatica, hydrocyanicum acidum, panax quinquefolius whole panax quinquefolius whole epifagus virginiana epifagus virginiana jacaranda caroba flower jacaranda caroba flower lactic acid, dl- lactic acid, dl- centella asiatica centella asiatica hydrogen cyanide hydrogen cyanide water alcohol

Indications and Usage:

Indications improves hypertrophy, muscular weakness, stiffness in joints and lactic acid buildup due to prolonged physical effort.

Warnings:

Warnings keep out of reach of children. in case of overdose, get medical help or contct a poison control center right away. if pregnant or breast-feeding, ask a health professional before use. safety sealed with a printed outer seal. do not use if seal is broken or missing. store in a cool, dry area.

Dosage and Administration:

Directions for ages 12 and over take 10-20 drops under the tongue on an empty stomach as an addition to daily diet. hold 30 seconds, then swallow. use prior to intense physical activity along with proper diet. consult a health professional for use in dchildren under 12 years of age.

Package Label Principal Display Panel:

Package label display homeopathic medicine ndc#49892-0002-1 musco mxt muscle weakness/joint stiffness 1 fl. oz (29.6 ml) musco mxt

Further Questions:

Questions manufactured for: sandco international, inc. northport, al 35473 1-800-367-9599 made in u.s.a.


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.